BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 3537070)

  • 21. Valvular and structural heart disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Salem DN; O'Gara PT; Madias C; Pauker SG
    Chest; 2008 Jun; 133(6 Suppl):593S-629S. PubMed ID: 18574274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An overview of artificial heart valve replacement in infants and children.
    Tong E
    J Cardiovasc Nurs; 1992 Apr; 6(3):30-43. PubMed ID: 1556584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticoagulation in pregnancy.
    Goland S; Elkayam U
    Cardiol Clin; 2012 Aug; 30(3):395-405. PubMed ID: 22813365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thromboembolism in pregnant women with mechanical prosthetic heart valves anticoagulated with low molecular weight heparin.
    Roberts N; Ross D; Flint SK; Arya R; Blott M
    BJOG; 2001 Mar; 108(3):327-9. PubMed ID: 11281477
    [No Abstract]   [Full Text] [Related]  

  • 25. [Intensity of oral anticoagulant therapy after heart valve replacement].
    Stenzinger W
    Z Kardiol; 1998; 87 Suppl 4():37-41. PubMed ID: 9857465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Valvular heart disease, infected valves and prosthetic heart valves.
    Dalen JE
    Am J Cardiol; 1990 Feb; 65(6):29C-31C. PubMed ID: 2405624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Recommendations for prevention of thromboembolism in heart valve diseases. Working Group on Valvular Heart Disease, European Society of Cardiology].
    Gohlke-Bärwolf C; Acar J; Oakley C; Butchart E; Burckhardt D; Delahaye JP; Horstkotte D; Bodnar E; Hall R; Kremer R
    Z Kardiol; 1995 Dec; 84(12):1018-32. PubMed ID: 8578786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurologic complications of nonrheumatic valvular heart disease.
    Cruz-Flores S
    Handb Clin Neurol; 2021; 177():33-41. PubMed ID: 33632451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors affecting performance and thromboembolism after porcine xenograft cardiac valve replacement.
    Geha AS; Hammond GL; Laks H; Stansel HC; Glenn WW
    J Thorac Cardiovasc Surg; 1982 Mar; 83(3):377-84. PubMed ID: 7062749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticoagulation in cardiac diseases. Prevention and control of thromboembolic events.
    Genton E
    Postgrad Med; 1985 May; 77(6):109-12, 116. PubMed ID: 3991379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticoagulation After Heart Valve Replacement or Transcatheter Valve Implantation.
    Carnicelli AP; O'Gara PT; Giugliano RP
    Am J Cardiol; 2016 Nov; 118(9):1419-1426. PubMed ID: 27666180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic thromboembolism in valvular heart disease and prosthetic heart valves.
    Pumphrey CW; Fuster V; Chesebro JH
    Mod Concepts Cardiovasc Dis; 1982 Dec; 51(12):131-6. PubMed ID: 7155121
    [No Abstract]   [Full Text] [Related]  

  • 33. Anticoagulant therapy in children with prosthetic valves.
    Rao PS; Solymar L; Mardini MK; Fawzy ME; Guinn G
    Ann Thorac Surg; 1989 Apr; 47(4):589-92. PubMed ID: 2712632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
    Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticoagulant choices in pregnant women with mechanical heart valves: balancing maternal and fetal risks--the difference the dose makes.
    McLintock C
    Thromb Res; 2013 Jan; 131 Suppl 1():S8-10. PubMed ID: 23452748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of patients with prosthetic heart valves: potential impact of valve site, clinical characteristics, and comorbidity.
    Mercadante N
    J Thromb Thrombolysis; 2000 Aug; 10(1):29-34. PubMed ID: 10947912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of low molecular weight heparin in pregnant women with mechanical heart valves.
    Yinon Y; Siu SC; Warshafsky C; Maxwell C; McLeod A; Colman JM; Sermer M; Silversides CK
    Am J Cardiol; 2009 Nov; 104(9):1259-63. PubMed ID: 19840573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-molecular-weight heparin in pregnant women with prosthetic heart valves.
    Descarries LM; Leduc L; Khairy P; Mercier LA
    J Heart Valve Dis; 2006 Sep; 15(5):679-85. PubMed ID: 17044374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombosis and embolism from cardiac chambers and infected valves.
    Adams PC; Cohen M; Chesebro JH; Fuster V
    J Am Coll Cardiol; 1986 Dec; 8(6 Suppl B):76B-87B. PubMed ID: 3537072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of Different Anticoagulation Regimens Regarding Maternal and Fetal Outcomes in Pregnant Patients With Mechanical Prosthetic Heart Valves (from the Multicenter ANATOLIA-PREG Registry).
    Güner A; Kalçık M; Gürsoy MO; Gündüz S; Astarcıoğlu MA; Bayam E; Kalkan S; Yesin M; Karakoyun S; Özkan M
    Am J Cardiol; 2020 Jul; 127():113-119. PubMed ID: 32375999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.